228 related articles for article (PubMed ID: 15231368)
1. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.
Baba A; Yoshikawa T; Fukuda Y; Sugiyama T; Shimada M; Akaishi M; Tsuchimoto K; Ogawa S; Fu M
Eur Heart J; 2004 Jul; 25(13):1108-15. PubMed ID: 15231368
[TBL] [Abstract][Full Text] [Related]
2. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.
Baba A
Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158
[TBL] [Abstract][Full Text] [Related]
3. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo.
Hong CM; Zheng QS; Liu XT; Shang FJ; Wang HT; Jiang WR
Cardiology; 2009; 112(3):180-7. PubMed ID: 18679026
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic subtype-2 receptor autoantibodies: actors or bystanders in human atrial fibrillation?
Dobrev D; Christ T; Ravens U
Eur Heart J; 2004 Jul; 25(13):1091-2. PubMed ID: 15231365
[No Abstract] [Full Text] [Related]
5. [Autoantibodies: new upstream targets of paroxysmal atrial fibrillation in patients with congestive heart failure].
Baba A; Yoshikawa T; Chino M; Murayama A; Mitani K; Nakagawa S; Fujii I; Shimada M; Koyama T; Akaishi M; Mitamura H; Ogawa S;
J Cardiol; 2002 Nov; 40(5):217-23. PubMed ID: 12463096
[TBL] [Abstract][Full Text] [Related]
6. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
Fu LX; Magnusson Y; Bergh CH; Liljeqvist JA; Waagstein F; Hjalmarson A; Hoebeke J
J Clin Invest; 1993 May; 91(5):1964-8. PubMed ID: 7683693
[TBL] [Abstract][Full Text] [Related]
7. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation.
Gurses KM; Yalcin MU; Kocyigit D; Kesikli SA; Canpolat U; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Ozer N; Oto MA; Guc D; Aytemir K
Europace; 2015 Feb; 17(2):239-46. PubMed ID: 25238749
[TBL] [Abstract][Full Text] [Related]
8. [Autoantibodies against sarcolemmal Na-K-ATPase in patients with dilated cardiomyopathy: autoimmune basis for ventricular arrhythmias in patients with congestive heart failure].
Baba A; Yoshikawa T; Mitamura H; Akaishi M; Ogawa S
J Cardiol; 2002 Jan; 39(1):50-1. PubMed ID: 11828798
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
[TBL] [Abstract][Full Text] [Related]
10. The effects of autoantibodies against the second extracellular loop of alpha(1)-adrenoceptor on vasoconstriction.
Yan L; Xu Y; Yao H; Xue W; Tian J; Ren H; Wu Y; Yang G; Ma XL; Liu H
Basic Res Cardiol; 2009 Sep; 104(5):581-9. PubMed ID: 19330480
[TBL] [Abstract][Full Text] [Related]
11. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in atrial fibrillation: actor, biomaker or bystander?
Baba A; Fu M
Autoimmunity; 2008 Sep; 41(6):470-2. PubMed ID: 18781473
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
Lauer B; Padberg K; Schultheiss HP; Strauer BE
Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
[TBL] [Abstract][Full Text] [Related]
15. Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.
Hu B; Sun Y; Li S; Sun J; Liu T; Wu Z; Feng LI
Pacing Clin Electrophysiol; 2016 Dec; 39(12):1379-1387. PubMed ID: 27862036
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities.
Chiale PA; Rosenbaum MB; Elizari MV; Hjalmarson A; Magnusson Y; Wallukat G; Hoebeke J
J Am Coll Cardiol; 1995 Oct; 26(4):864-9. PubMed ID: 7560610
[TBL] [Abstract][Full Text] [Related]
17. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
Warraich RS; Dunn MJ; Yacoub MH
Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496
[TBL] [Abstract][Full Text] [Related]
18. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.
Stavrakis S; Yu X; Patterson E; Huang S; Hamlett SR; Chalmers L; Pappy R; Cunningham MW; Morshed SA; Davies TF; Lazzara R; Kem DC
J Am Coll Cardiol; 2009 Sep; 54(14):1309-16. PubMed ID: 19778674
[TBL] [Abstract][Full Text] [Related]
19. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R
Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity against M₂muscarinic acetylcholine receptor induces myocarditis and leads to a dilated cardiomyopathy-like phenotype.
Yoshizawa A; Nagai S; Baba Y; Yamada T; Matsui M; Tanaka H; Miyoshi S; Amagai M; Yoshikawa T; Fukuda K; Ogawa S; Koyasu S
Eur J Immunol; 2012 May; 42(5):1152-63. PubMed ID: 22328321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
